Mitzy Mauthe von Degerfeld

Dr. Mitzy Mauthe von Degerfeld

Department of Veterinary Sciences, University of Turin, Turin, Piedmont, Italy
orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in BioMed Research International
Verified
Journal Article
Open access
PDF file
Gianmario SchieranoGianmario Schierano
Gianmario Schierano
Federico MussanoFederico Mussano
Federico Mussano
MFMaria Giulia Faga
Maria Giulia Faga
GMGiulio Menicucci
Giulio Menicucci
CMCarlo Manzella
Carlo Manzella
SCStefano Carossa
Stefano Carossa
Ceramic materials are widely used for biomedical applications because of their remarkable biological and mechanical properties. Composites made of alumina and zirconia are particularly interesting owing to their higher toughness with respect to the monolithic materials. On this basis, the present study is focused on thein vivobehavior of alumina toughened zirconia (ATZ) dental implants treated with a hydrothermal process. A minipig model was implemented to assess the bone healing through histology and mRNA expression at different time points (8, 14, 28, and 56 days). The novel ATZ implant was compared to a titanium clinical standard. The implants were analyzed in terms of microstructure and surface roughness beforein vivotests. The most interesting result deals with a statistically significant higher digital histology index for ATZ implants with respect to titanium standard at 56 days, which is an unprecedented finding, to the authors’ knowledge. Even if further investigations are needed before proposing the clinical use in humans, the tested material proved to be a promising candidate among the possible ceramic dental implants.

30 April 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PBPenelope Banchi
Penelope Banchi
GQGiuseppe Quaranta
Giuseppe Quaranta
ARAlessandro Ricci
Alessandro Ricci
Mitzy Mauthe von DegerfeldMitzy Mauthe von Degerfeld
Mitzy Mauthe von Degerfeld
A composite pain scale for assessing and quantifying pain in rabbits (CANCRS) has been designed merging the Rabbit Grimace Scale (RbtGS) and a scale including clinical parameters (CPS). Construct validity and inter-rater reliability were assessed for CANCRS, for RbtGS and for CPS, in order to test their potential to detect pain in a clinical setting. Rabbits (n = 116) were either hybrids or purebreds and they were independently evaluated by two raters, who could be veterinarians (V) or veterinary medicine students (S). Score intervals determined four pain classes (No pain, Discomfort, Moderate pain and Severe pain) that matched presumptive pain classes associated with some pathological conditions. A chi-square test was used to assess the construct validity of the scales by checking how frequently scale results and presumptive pain classes matched. Sixty-nine patients were evaluated by one V and one S, whereas forty-seven rabbits were assessed by two V, in order to test inter-rater reliability. An intra-class correlation coefficient (ICC) was used to test reliability of the scales, whereas Cohen’s kappa tested inter-rater agreement for each parameter of the CANCRS. Construct validity results show that CANCRS and RbtGS efficiently reveal pain (P ≤ 0.05), while CPS does not (p > 0.05). Inter-rater reliability was very good for both CANCRS and CPS (ICC 0.88 V-V, 0.94 between V-S; ICC 0.97 V-V, 0.91 V-S) and good for RbtGS (ICC 0.77 V-V, 0.88 V-S); therefore, CPS reproducibility was better between veterinarians and students than between veterinarians. Inter-rater agreement between veterinarians and veterinary medicine students was moderate to very good for all the parameters included in the CANCRS (Cohen’s kappa >0,60). In conclusion, it is possible to state that the CANCRS has construct validity and it is a reliable tool for use in clinical practice, when coping with many rabbits with morphological differences. It is easy and fast to use and enriches the RbtGS with some clinical parameters that should be monitored during any clinical examination, allowing for capture of the multidimensional aspect of pain.

4 August 2013
Verified
Journal Article
Closed access
Antonio MarmottiAntonio Marmotti
Antonio Marmotti
MBM Bruzzone
M Bruzzone
DBDavide Edoardo Bonasia
Davide Edoardo Bonasia
FCFilippo Castoldi
Filippo Castoldi
Mitzy Mauthe von DegerfeldMitzy Mauthe von Degerfeld
Mitzy Mauthe von Degerfeld
GPGm Peretti
Gm Peretti
We propose a culture-free approach to osteochondral repair with minced autologous cartilage fragments loaded onto a scaffold composed of a hyaluronic acid (HA)-derived membrane, platelet-rich fibrin matrix (PRFM) and fibrin glue. The aim of the study was to demonstrate in vitro the outgrowth of chondrocytes from cartilage fragments onto this scaffold and, in vivo, the formation of functional repair tissue in goat osteochondral defects. Two sections were considered: 1) in vitro: minced articular cartilage from goat stifle joints was loaded onto scaffolds, cultured for 1 or 2 months, and then evaluated histologically and immunohistochemically; 2) in vivo: 2 unilateral critically-sized trochlear osteochondral defects were created in 15 adult goats; defects were treated with cartilage fragments embedded in the scaffold (Group 1), with the scaffold alone (Group 2), or untreated (Group 3). Repair processes were evaluated morphologically, histologically, immunohistochemically and biomechanically at 1, 3, 6 and 12 months. We found that in vitro, chondrocytes from cartilage fragments migrated to the scaffold and, at 2 months, matrix positive for collagen type II was observed in the constructs. In vivo, morphological and histological assessment demonstrated that cartilage fragment-loaded scaffolds led to the formation of functional hyaline-like repair tissue. Repair in Group 1 was superior to that of control groups, both histologically and mechanically. Autologous cartilage fragments loaded onto an HA/PRFM/fibrin glue scaffold provided a viable cell source and allowed for an improvement of the repair process of osteochondral defects in a goat model, representing an effective alternative for one-stage repair of osteochondral lesions.

21 January 2020 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Closed access
PDF file
VRVincenza Ragone
Vincenza Ragone
Elena CancianiElena Canciani
Elena Canciani
MAMassimo Arosio
Massimo Arosio
MOMatteo Olimpo
Matteo Olimpo
LPLisa Adele Piras
Lisa Adele Piras
Claudia DellaviaClaudia Dellavia
Claudia Dellavia

3 January 2023 in Comparative Immunology, Microbiology and Infectious Diseases
Verified
Journal Article
Closed access
IPIlaria Prandi
Ilaria Prandi
ABAlessandro Bellato
Alessandro Bellato
Patrizia NebbiaPatrizia Nebbia
Patrizia Nebbia
MSMaria Cristina Stella
Maria Cristina Stella
UAUgo Ala
Ugo Ala
PRPatrizia Robino
Patrizia Robino

24 April 2021 in Materials
Verified
Journal Article
Open access
PDF file
Gianmario SchieranoGianmario Schierano
Gianmario Schierano
RCRosa Angela Canuto
Rosa Angela Canuto
Mitzy Mauthe von DegerfeldMitzy Mauthe von Degerfeld
Mitzy Mauthe von Degerfeld
RNRoberto Navone
Roberto Navone
BPBruno Peirone
Bruno Peirone
Giuliana MuzioGiuliana Muzio
Giuliana Muzio
Background: The biological factors involved in dental implant osseointegration need to be investigated to improve implant success. Methods: Twenty-four implants were inserted into the tibias of six minipigs. Bone samples were obtained at 7, 14, and 56 days. Biomolecular analyses evaluated mRNA of BMP-4, -7, Transforming Growth Factor-β2, Interleukin-1β, and Osteocalcin in sites treated with rhBMP-7, Type 1 Collagen, or Fibronectin (FN). Inflammation and osteogenesis were evaluated by histological analyses. Results: At 7 and 14 days, BMP-4 and BMP-7 increased in the sites prepared with rhBMP-7 and FN. BMP-7 remained greater at 56 days in rhBMP-7 and FN sites. BPM-4 at 7 and 14 days increased in Type 1 Collagen sites; BMP-7 increased from day 14. FN increased the TGF-β2 at all experimental times, whilst the rhBMP-7 only did so up to 7 days. IL-1β increased only in collagen-treated sites from 14 days. Osteocalcin was high in FN-treated sites. Neutrophilic granulocytes characterized the inflammatory infiltrate at 7 days, and mononuclear cells at 14 and 56 days. Conclusions: This initial pilot study, in a novel way, evidenced that Type 1 Collagen induced inflammation and did not stimulate bone production; conversely FN or rhBMP-7 showed neo-osteogenetic and anti-inflammatory properties when directly added into implant bone site.